tiprankstipranks
Applied DNA Sciences (GB:0HGQ)
LSE:0HGQ

Applied DNA Sciences (0HGQ) Share Price & Analysis

0 Followers

0HGQ Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

Bulls Say, Bears Say

Bulls Say
Financial StabilityWith sufficient capital raised recently, APDN is expected to have enough funds to last into the end of FY24.
Product AdvancementThe company's Linea IVT templates are on track to achieve cGMP status, which will likely expand the customer base.
Strategic DevelopmentAPDN's strategy to develop into a CDMO positions it well within the biotherapeutics space for RNA-based and DNA-based medicines.
Bears Say
Earnings ExpectationDespite beating projections, the reported total revenue was just $0.9 million.
Earnings PerformanceTotal revenue showed a significant 83% year-over-year decline.
Future OutlookThe company issued soft guidance for the upcoming year, suggesting potential pressure on the stock.
---

Financials

Annual

0HGQ FAQ

What was Applied DNA Sciences’s price range in the past 12 months?
Currently, no data Available
What is Applied DNA Sciences’s market cap?
Currently, no data Available
When is Applied DNA Sciences’s upcoming earnings report date?
Applied DNA Sciences’s upcoming earnings report date is May 09, 2024 which is in 11 days.
    How were Applied DNA Sciences’s earnings last quarter?
    Applied DNA Sciences released its earnings results on Feb 08, 2024. The company reported -$1.8 earnings per share for the quarter, beating the consensus estimate of -$6.2 by $4.4.
      Is Applied DNA Sciences overvalued?
      According to Wall Street analysts Applied DNA Sciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does Applied DNA Sciences pay dividends?
        Applied DNA Sciences does not currently pay dividends.
        What is Applied DNA Sciences’s EPS estimate?
        Applied DNA Sciences’s EPS estimate is -$4.5.
          How many shares outstanding does Applied DNA Sciences have?
          Applied DNA Sciences has 16,978,703 shares outstanding.
            What happened to Applied DNA Sciences’s price movement after its last earnings report?
            Applied DNA Sciences reported an EPS of -$1.8 in its last earnings report, beating expectations of -$6.2. Following the earnings report the stock price went same N/A.
              Which hedge fund is a major shareholder of Applied DNA Sciences?
              Currently, no hedge funds are holding shares in GB:0HGQ
              ---

              Company Description

              Applied DNA Sciences

              Applied DNA Sciences, Inc. engages in the provision of security solutions. It offers molecular-based technology solutions and services that can help protect products, brands, supply chains, and intellectual property of companies, governments, and consumers from theft, counterfeiting, fraud, and diversion. Its products include the following brands: Applied DNA Sciences, SigNature, molecular tags, SigNature, T molecular tags, fiberTyping, DNAnet, digitalDNA, SigNify, BackTrac, Beacon, and CertainT. The company was founded in 1983 and is headquartered in Stony Brook, NY.
              ---

              0HGQ Company Deck

              ---

              0HGQ Earnings Call

              Q1 2024
              0:00 / 0:00
              ---

              0HGQ Stock 12 Months Forecast

              Average Price Target

              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
              Similar Stocks
              Company
              Price & Change
              Follow
              Applied DNA Sciences
              Precigen
              Fate Therapeutics
              Sarepta Therapeutics
              Meiragtx Holdings

              Best Analysts Covering 0HGQ

              1 Year
              Yi ChenH.C. Wainwright
              1 Year Success Rate
              0/16 ratings generated profit
              0%
              1 Year Average Return
              -60.68%
              reiterated a buy rating 3 months ago
              Copying Yi Chen's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -60.68% per trade.
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis